Mannose-based mRNA targeted delivery system and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11707528
SERIAL NO

17559620

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a mannose-based mRNA targeted delivery system and use thereof. The mRNA can encode one or more target polypeptides and contains at least one mannose modification. The technical solution of the present invention modifies the mRNA molecule with a mannose, so that the mRNA can be directly and efficiently coupled with the mannose, and the targeted delivery of the mRNA is realized without the need for a carrier.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SHENZHEN RHEGEN BIOTECHNOLOGY CO LTDSHENZHEN 518057

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hu, Yong Shenzhen, CN 114 1355
Zhang, Miaomiao Shenzhen, CN 26 102

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jan 25, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 25, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 25, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00